Correlation Between National CineMedia and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both National CineMedia and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining National CineMedia and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between National CineMedia and Mink Therapeutics, you can compare the effects of market volatilities on National CineMedia and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in National CineMedia with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of National CineMedia and Mink Therapeutics.
Diversification Opportunities for National CineMedia and Mink Therapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between National and Mink is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding National CineMedia and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and National CineMedia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on National CineMedia are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of National CineMedia i.e., National CineMedia and Mink Therapeutics go up and down completely randomly.
Pair Corralation between National CineMedia and Mink Therapeutics
Given the investment horizon of 90 days National CineMedia is expected to under-perform the Mink Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, National CineMedia is 3.62 times less risky than Mink Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Mink Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 630.00 in Mink Therapeutics on December 28, 2024 and sell it today you would earn a total of 273.00 from holding Mink Therapeutics or generate 43.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
National CineMedia vs. Mink Therapeutics
Performance |
Timeline |
National CineMedia |
Mink Therapeutics |
National CineMedia and Mink Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with National CineMedia and Mink Therapeutics
The main advantage of trading using opposite National CineMedia and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if National CineMedia position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.National CineMedia vs. Baosheng Media Group | National CineMedia vs. Impact Fusion International | National CineMedia vs. ZW Data Action | National CineMedia vs. Aquagold International |
Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |